Key statistics
As of last trade Insulet Corp (GOV:FRA) traded at 210.20, -3.04% below its 52-week high of 216.80, set on Sep 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 210.20 |
---|---|
High | 210.20 |
Low | 210.20 |
Bid | 210.30 |
Offer | 215.40 |
Previous close | 211.90 |
Average volume | 59.11 |
---|---|
Shares outstanding | 70.12m |
Free float | 69.88m |
P/E (TTM) | 43.92 |
Market cap | 16.67bn USD |
EPS (TTM) | 5.41 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 07:05 BST.
More ▼
Press releases
- Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
- Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia
- Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year
- Insulet Reports Preliminary Second Quarter 2024 Revenue Results
- Imperative Care Completes Initial Closing of Series E Financing for up to $150 Million; Shacey Petrovic Appointed to Vice Chair, Board of Directors
- Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
More ▼